Silexion Therapeutics (SLXN) Competitors $0.24 -0.05 (-17.12%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsSEC FilingsTrends SLXN vs. MKDW, DMAQ, PSIG, CGBS, JMAC, QFTA, NSTC, NCNC, NSTD, and MCAEShould you be buying Silexion Therapeutics stock or one of its competitors? The main competitors of Silexion Therapeutics include MKDWELL Tech (MKDW), Deep Medicine Acquisition (DMAQ), PSI Group (PSIG), Crown LNG (CGBS), Maxpro Capital Acquisition (JMAC), Quantum FinTech Acquisition (QFTA), Northern Star Investment Corp. III (NSTC), noco-noco (NCNC), Northern Star Investment Corp. IV (NSTD), and Mountain Crest Acquisition Corp. III (MCAE). These companies are all part of the "holding & other investment offices" industry. Silexion Therapeutics vs. MKDWELL Tech Deep Medicine Acquisition PSI Group Crown LNG Maxpro Capital Acquisition Quantum FinTech Acquisition Northern Star Investment Corp. III noco-noco Northern Star Investment Corp. IV Mountain Crest Acquisition Corp. III MKDWELL Tech (NASDAQ:MKDW) and Silexion Therapeutics (NASDAQ:SLXN) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations. Is MKDW or SLXN more profitable? Company Net Margins Return on Equity Return on Assets MKDWELL TechN/A N/A N/A Silexion Therapeutics N/A N/A -32.34% Do insiders & institutionals have more ownership in MKDW or SLXN? 70.0% of MKDWELL Tech shares are owned by institutional investors. Comparatively, 11.0% of Silexion Therapeutics shares are owned by institutional investors. 22.9% of MKDWELL Tech shares are owned by insiders. Comparatively, 33.0% of Silexion Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media refer more to MKDW or SLXN? In the previous week, Silexion Therapeutics had 2 more articles in the media than MKDWELL Tech. MarketBeat recorded 2 mentions for Silexion Therapeutics and 0 mentions for MKDWELL Tech. Silexion Therapeutics' average media sentiment score of 0.50 beat MKDWELL Tech's score of 0.00 indicating that Silexion Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment MKDWELL Tech Neutral Silexion Therapeutics Positive Which has preferable valuation and earnings, MKDW or SLXN? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMKDWELL TechN/AN/AN/AN/AN/ASilexion TherapeuticsN/AN/A$260KN/AN/A Does the MarketBeat Community believe in MKDW or SLXN? Silexion Therapeutics received 1 more outperform votes than MKDWELL Tech when rated by MarketBeat users. CompanyUnderperformOutperformMKDWELL TechN/AN/ASilexion TherapeuticsOutperform Votes1100.00% Underperform VotesNo Votes Do analysts rate MKDW or SLXN? Silexion Therapeutics has a consensus price target of $1.00, indicating a potential upside of 313.22%. Given Silexion Therapeutics' higher possible upside, analysts clearly believe Silexion Therapeutics is more favorable than MKDWELL Tech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MKDWELL Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ASilexion Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, MKDW or SLXN? MKDWELL Tech has a beta of 0.23, suggesting that its stock price is 77% less volatile than the S&P 500. Comparatively, Silexion Therapeutics has a beta of -0.19, suggesting that its stock price is 119% less volatile than the S&P 500. SummarySilexion Therapeutics beats MKDWELL Tech on 6 of the 9 factors compared between the two stocks. Ad Porter & CompanyTrue paradigm shiftI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Get Silexion Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLXN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLXN vs. The Competition Export to ExcelMetricSilexion TherapeuticsHolding Offices IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.35M$420.55M$5.40B$8.53BDividend YieldN/A8.07%5.13%4.14%P/E RatioN/A9.04113.4615.10Price / SalesN/A99.771,484.4093.54Price / Cash4.3374.9539.6434.05Price / Book-0.3374.234.655.02Net Income$260,000.00$31.01M$119.06M$225.46M7 Day Performance-21.10%-0.84%0.79%0.37%1 Month Performance-55.35%-0.47%5.65%3.57%1 Year PerformanceN/A11.58%36.76%29.42% Silexion Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLXNSilexion TherapeuticsN/A$0.24-17.1%$1.00+313.2%N/A$3.35MN/A0.00N/AAnalyst ForecastNews CoveragePositive NewsGap DownMKDWMKDWELL TechN/A$0.96-1.0%N/AN/A$3.69M$3.67M0.00N/AGap UpDMAQDeep Medicine AcquisitionN/A$0.70flatN/A-94.9%$3.04MN/A0.0093Gap DownHigh Trading VolumePSIGPSI GroupN/A$0.80flatN/AN/A$2.90M$140.02M0.00N/ANews CoverageCGBSCrown LNGN/A$0.29-3.3%N/AN/A$2.58MN/A-0.335Gap UpJMACMaxpro Capital AcquisitionN/A$0.14flatN/A-85.1%$1.83MN/A0.002,021Gap DownHigh Trading VolumeQFTAQuantum FinTech AcquisitionN/A$0.17-5.6%N/A-98.5%$1.71MN/A0.003High Trading VolumeNSTCNorthern Star Investment Corp. IIIN/A$0.05flatN/AN/A$700,000.00N/A0.003Gap DownHigh Trading VolumeNCNCnoco-nocoN/A$0.11-8.7%N/A-76.4%$374,000.00N/A0.0012Gap DownNSTDNorthern Star Investment Corp. IVN/A$0.01flatN/AN/A$142,000.00N/A0.003MCAEMountain Crest Acquisition Corp. IIIN/A$0.00flatN/A-99.8%$2,000.00N/A0.002,021Gap Down Related Companies and Tools Related Companies MKDWELL Tech Alternatives Deep Medicine Acquisition Alternatives PSI Group Alternatives Crown LNG Alternatives Maxpro Capital Acquisition Alternatives Quantum FinTech Acquisition Alternatives Northern Star Investment Corp. III Alternatives noco-noco Alternatives Northern Star Investment Corp. IV Alternatives Mountain Crest Acquisition Corp. III Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SLXN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silexion Therapeutics Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Silexion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
